Phibro Animal Health Corporation Class A (PAHC) Stock Price, Quote & AI Analysis

Live PAHC stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Phibro Animal Health Corporation Class A.

TradeVae provides AI-driven analysis and real-time market intelligence for Phibro Animal Health Corporation Class A (PAHC), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

PAHC
Phibro Animal Health Corporation Class A
real-time
$0.00 +0.00 (+0.00%)
Open
40.220000
High
41.550000
Low
39.985000
Volume
74,892
VWAP
-
Market Cap
$1,572,703,990.40
52W Range
$16.16 - $46.42
P/E Ratio
-
EPS
-
Dividend Yield
119.55%
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 11, 2026 Q2
Market
EPS Estimate: $0.6834
Revenue Estimate: $362,749,403.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Phibro Animal Health Corporation Class A's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Phibro Animal Health Corporation Class A Overview

Company information

Company Overview

Phibro Animal Health Corp. engages in the development, manufacture, and marketing of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment focuses on the development and marketing of medicated feed additives, nutritional specialty products, and vaccines. The Mineral Nutrition segment includes formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment is involved in the manufacture and marketing of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Company Details
Market Cap
$1.66B
Shares Outstanding
40,533,634
Weighted Shares Outstanding
40,533,608
CEO
Jack C. Bendheim
Address
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ, 07666
Employees
2,475
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Phibro Animal Health Corporation Class A Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...